Industry Leader Climet Partners with Phizzle; Pioneers Joint TCO/ROI Value Proposition in Pharma Manufacturing

San Francisco, California – December 19, 2024 – Climet has officially announced that it has partnered with Phizzle, Inc. as an authorized software partner. This collaboration marks a significant development in the pharmaceutical manufacturing sector, focusing on improving operational efficiency and data management.

Key Features of the Partnership

The partnership between Climet and Phizzle aims to automate data collection processes. This shift towards automation is set to reduce the reliance on manual labor within organizations, leading to enhanced data integrity. By leveraging advanced technology, companies in the pharmaceutical manufacturing industry can streamline their operations and minimize the chances of human error.

Potential Return on Investment

The collaboration is designed to offer organizations the potential for a remarkable return on investment (ROI), estimated at over 1000%. Companies can expect to see a payback on their investment in less than 12 months, making this partnership a financially attractive option for many businesses in the sector.

Improving Audit Preparedness

Seamless integration provided through this partnership will also improve audit readiness for organizations. By simplifying data management processes, companies can minimize deviation reports and ensure they are better prepared for inspections and audits.

Phizzle’s Digital Air Solution

Phizzle’s Digital Air Solution is noteworthy as the only GMP-compliant platform currently in production. This platform features a software-defined, microservices architecture that supports the need for flexibility and scalability in data management operations.

Overall, the partnership between Climet and Phizzle represents an innovative step towards optimizing pharmaceutical manufacturing through effective data management and improved ROI.

partnership, pharmaceutical, technology